BMY Bristol Myers Squibb Loading...

From ARE earnings calls
Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
18:00
Aug 04 ◎
Marc (Chief Financial Officer) ARE Q2 FY26 call
Bristol Myers took a large, long-term build-to-suit at Alexandria's mega campus, indicating significant commitment to the region and strengthening ARE's income visibility.
BMY
HIGH
18:00
Apr 28 ◎
Joel Marcus Executive Chairman and Founder, Alexandria Real Estate Equi… ARE Q1 FY26 call
Bristol-Myers is a key tenant taking space at a new research hub, showing continued demand for high-quality lab space from large pharma.
BMY
HIGH

About BMY Analyst Coverage

Buzzberg tracks BMY (Bristol Myers Squibb) across 1 sources. 0 bullish vs 0 bearish calls from 2 analysts. Sentiment: evenly split. 2 total trade ideas tracked. Latest voices: Marc (Chief Financial Officer), Joel Marcus.